NEW YORK, Dec. 2 (GenomeWeb News) - The University of Michigan Medical School has won a $5.9 million grant from the National Institute of Allergy and Infectious Diseases to apply its proteomics research to help develop a widely used anthrax vaccine, the school said today.
Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.
In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.
